ATE442355T1 - Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung - Google Patents

Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung

Info

Publication number
ATE442355T1
ATE442355T1 AT04796917T AT04796917T ATE442355T1 AT E442355 T1 ATE442355 T1 AT E442355T1 AT 04796917 T AT04796917 T AT 04796917T AT 04796917 T AT04796917 T AT 04796917T AT E442355 T1 ATE442355 T1 AT E442355T1
Authority
AT
Austria
Prior art keywords
synthesis
acylpyrrol
fink
fischer
dialkyl
Prior art date
Application number
AT04796917T
Other languages
English (en)
Inventor
Michael Wallace
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Application granted granted Critical
Publication of ATE442355T1 publication Critical patent/ATE442355T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04796917T 2003-10-28 2004-10-28 Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung ATE442355T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51528303P 2003-10-28 2003-10-28
PCT/US2004/037985 WO2005042484A1 (en) 2003-10-28 2004-10-28 Preparation of 4,5-dialkyl-3-acyl-pyrrole-2-carboxylic acid derivatives by fischer-fink type synthesis and subsequent acylation

Publications (1)

Publication Number Publication Date
ATE442355T1 true ATE442355T1 (de) 2009-09-15

Family

ID=34549387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04796917T ATE442355T1 (de) 2003-10-28 2004-10-28 Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung

Country Status (11)

Country Link
US (2) US7250520B2 (de)
EP (1) EP1678134B1 (de)
JP (2) JP4942485B2 (de)
KR (1) KR20060122872A (de)
CN (1) CN1894211A (de)
AT (1) ATE442355T1 (de)
AU (1) AU2004285972A1 (de)
DE (1) DE602004023105D1 (de)
ES (1) ES2330944T3 (de)
IL (1) IL175253A0 (de)
WO (1) WO2005042484A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ335276A (en) 1996-10-18 2000-09-29 Vertex Pharma Inhibitors of serine proteases, particularly hepatitis C virus (HCV) NS3 (Non Structural Protein 3) protease
SV2003000617A (es) 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
MY148123A (en) 2003-09-05 2013-02-28 Vertex Pharma Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
US8399615B2 (en) 2005-08-19 2013-03-19 Vertex Pharmaceuticals Incorporated Processes and intermediates
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AR055395A1 (es) 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
EP1991229A2 (de) 2006-02-27 2008-11-19 Vertex Pharmaceuticals Incorporated Kokristalle und pharmazeutische zusammensetzungen damit
JP2009531315A (ja) 2006-03-16 2009-09-03 バーテックス ファーマシューティカルズ インコーポレイテッド 重水素化ｃ型肝炎プロテアーゼインヒビター
US8575208B2 (en) 2007-02-27 2013-11-05 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
EA200970806A1 (ru) 2007-02-27 2010-08-30 Вертекс Фармасьютикалз Инкорпорейтед Сокристаллы и содержащие их фармацевтические композиции
EP2436682A1 (de) 2007-08-30 2012-04-04 Vertex Pharmceuticals Incorporated Kokristalle und pharmazeutische Zusammensetzungen damit
EP2489346A1 (de) 2011-01-26 2012-08-22 NanotecMARIN GmbH Nahrungsergänzungsmittel und injizierbares Material zur Prophylaxe und Behandlung von Osteoporose und anderen Knochenerkrankungen
JP2015053226A (ja) 2013-09-09 2015-03-19 タイコエレクトロニクスジャパン合同会社 電気コネクタの端子、及び電気コネクタ
US10207974B1 (en) 2017-12-05 2019-02-19 Chevron Phillips Chemical Company Lp Synthesis of gamma dicarbonyl and pyrrole compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1497282A2 (de) * 2002-04-11 2005-01-19 Vertex Pharmaceuticals Incorporated Hemmer der serin-protease, besonders der ns3-ns4-protease des hepatitis-c-virus
US7365092B2 (en) * 2003-10-10 2008-04-29 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Also Published As

Publication number Publication date
US20080167480A1 (en) 2008-07-10
ES2330944T3 (es) 2009-12-17
JP2011231117A (ja) 2011-11-17
US7250520B2 (en) 2007-07-31
HK1092134A1 (en) 2007-02-02
KR20060122872A (ko) 2006-11-30
EP1678134B1 (de) 2009-09-09
IL175253A0 (en) 2006-09-05
JP4942485B2 (ja) 2012-05-30
US20050143585A1 (en) 2005-06-30
WO2005042484A1 (en) 2005-05-12
JP2007509991A (ja) 2007-04-19
CN1894211A (zh) 2007-01-10
EP1678134A1 (de) 2006-07-12
DE602004023105D1 (de) 2009-10-22
AU2004285972A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
CY1109055T1 (el) 11-((4r,6r)-4,5,6-τριϋδροξυ-3-(r)-υδροξυ-εξυλοκαρβαμοϋλο)-ενδεκαϊνικο οξυ
BR0307432A (pt) Difluormetiltiazolilcarboxanilidas
NO20051052L (no) Rutheniumkomplekser som (pre) katalysatorer for metatesereaksjoner
MXPA04000622A (es) Pirazolilcarboxanilidas como funguicidas.
PL371414A1 (en) Disubstituted thiazolyl carboxanilides and their use as microbicides
ATE388952T1 (de) Imidazopyridazinon- und imidazopyridonderivate, deren herstellung und deren verwendung als arzneimittel
ATE361924T1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE50207584D1 (de) Zusammensetzungen für die Herstellung von Formkörpern aus feinteiligen Materialien
WO2004084453A3 (en) METHODS OF MANUFACTURE OF 2'-DEOXY-β-L-NUCLEOSIDES
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
ATE430160T1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
DE602004023105D1 (de) HERSTELLUNG VON 4,5-DIALKYL-3-ACYLPYRROL-2-CARBONS ANSCHLIEßENDE ACYLIERUNG
EA200300066A1 (ru) Производные аминоалкоксибензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции
ATE409695T1 (de) Furancarboxamide
TW200745039A (en) Isotopically substituted pantoprazole
ATE454383T1 (de) Neue verbindungen, deren verwendung und herstellung
ES2333026T3 (es) Derivados de ciclohexil-1,4-diamina sustituidos.
WO2005042480A3 (de) N-substituierte pyrazolylcarboxanilide
ATE223414T1 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
TW200504036A (en) Novel lactams and uses thereof
WO2007002722A3 (en) Synthesis of anastrozole and purification of one of its intermediate
DE60112241D1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
ATE421961T1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties